BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27090847)

  • 1. The interaction of Clostridium perfringens enterotoxin with receptor claudins.
    Shrestha A; Uzal FA; McClane BA
    Anaerobe; 2016 Oct; 41():18-26. PubMed ID: 27090847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the interaction of Clostridium perfringens enterotoxin with claudins.
    Veshnyakova A; Protze J; Rossa J; Blasig IE; Krause G; Piontek J
    Toxins (Basel); 2010 Jun; 2(6):1336-56. PubMed ID: 22069641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin.
    Shrestha A; McClane BA
    mBio; 2013 Jan; 4(1):. PubMed ID: 23322640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium perfringens enterotoxin interacts with claudins via electrostatic attraction.
    Kimura J; Abe H; Kamitani S; Toshima H; Fukui A; Miyake M; Kamata Y; Sugita-Konishi Y; Yamamoto S; Horiguchi Y
    J Biol Chem; 2010 Jan; 285(1):401-8. PubMed ID: 19903817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins.
    Mitchell LA; Koval M
    Toxins (Basel); 2010 Jul; 2(7):1595-611. PubMed ID: 22069652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for
    Vecchio AJ; Rathnayake SS; Stroud RM
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications.
    Freedman JC; Shrestha A; McClane BA
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.
    Robertson SL; Smedley JG; McClane BA
    Infect Immun; 2010 Jan; 78(1):505-17. PubMed ID: 19884339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of a C. perfringens enterotoxin mutant in complex with a modified Claudin-2 extracellular loop 2.
    Yelland TS; Naylor CE; Bagoban T; Savva CG; Moss DS; McClane BA; Blasig IE; Popoff M; Basak AK
    J Mol Biol; 2014 Sep; 426(18):3134-3147. PubMed ID: 25020226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for disruption of claudin assembly in tight junctions by an enterotoxin.
    Shinoda T; Shinya N; Ito K; Ohsawa N; Terada T; Hirata K; Kawano Y; Yamamoto M; Kimura-Someya T; Yokoyama S; Shirouzu M
    Sci Rep; 2016 Sep; 6():33632. PubMed ID: 27647526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic peptide corresponding to the extracellular loop 2 region of claudin-4 protects against Clostridium perfringens enterotoxin in vitro and in vivo.
    Shrestha A; Robertson SL; Garcia J; Beingasser J; McClane BA; Uzal FA
    Infect Immun; 2014 Nov; 82(11):4778-88. PubMed ID: 25156725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants.
    Robertson SL; Smedley JG; Singh U; Chakrabarti G; Van Itallie CM; Anderson JM; McClane BA
    Cell Microbiol; 2007 Nov; 9(11):2734-55. PubMed ID: 17587331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis of
    Ogbu CP; Kapoor S; Vecchio AJ
    Toxins (Basel); 2023 Oct; 15(11):. PubMed ID: 37999500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
    Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
    J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Claudin-Made Tight Junction Barriers by
    Ogbu CP; Roy S; Vecchio AJ
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, structure, and mechanism of synthetic antibodies that target claudin and Clostridium perfringens enterotoxin complexes.
    Orlando BJ; Dominik PK; Roy S; Ogbu CP; Erramilli SK; Kossiakoff AA; Vecchio AJ
    J Biol Chem; 2022 Sep; 298(9):102357. PubMed ID: 35952760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Method to Prepare Claudin-Modulating Recombinant Proteins.
    Tachibana K; Kondoh M
    Methods Mol Biol; 2020; 2109():251-260. PubMed ID: 31471875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Colon Epithelia, Clostridium perfringens Enterotoxin Causes Focal Leaks by Targeting Claudins Which are Apically Accessible Due to Tight Junction Derangement.
    Eichner M; Augustin C; Fromm A; Piontek A; Walther W; Bücker R; Fromm M; Krause G; Schulzke JD; Günzel D; Piontek J
    J Infect Dis; 2017 Dec; 217(1):147-157. PubMed ID: 28968861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions.
    McClane BA
    Toxicon; 2001 Nov; 39(11):1781-91. PubMed ID: 11595640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.